These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7036277)

  • 61. Sequential combination chemotherapy in advanced breast cancer.
    Brambilla C; Valagussa P; Bonadonna G
    Cancer Chemother Pharmacol; 1978; 1(1):35-9. PubMed ID: 373906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Adjuvant chemotherapy in breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract]   [Full Text] [Related]  

  • 63. Editorial: Major advance in breast-cancer therapy.
    Holland JF
    N Engl J Med; 1976 Feb; 294(8):440-1. PubMed ID: 1246311
    [No Abstract]   [Full Text] [Related]  

  • 64. [Combined irradiation and chemotherapy as postoperative treatment of breast cancer].
    von der Maase H; Sveinsson T
    Ugeskr Laeger; 1978 Jul; 140(28):1676-8. PubMed ID: 695028
    [No Abstract]   [Full Text] [Related]  

  • 65. [Adjuvant chemotherapy in breast cancer: status in 1984].
    Jungi WF
    Wien Klin Wochenschr; 1984 Jun; 96(13):486-92. PubMed ID: 6382805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess JD; Valagussa P; Banfi A; Veronesi U
    Cancer Treat Rep; 1981; 65 Suppl 1():61-5. PubMed ID: 7034930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer.
    Radice D; Redaelli A
    Pharmacoeconomics; 2005; 23(1):69-75. PubMed ID: 15693729
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Hormone and chemotherapy of breast carcinoma].
    Rotte K; Caffier H
    Med Klin; 1977 Aug; 72(31):1263-9. PubMed ID: 331054
    [No Abstract]   [Full Text] [Related]  

  • 69. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 70. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
    Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
    Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.
    Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil].
    Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P
    Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425
    [No Abstract]   [Full Text] [Related]  

  • 73. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
    Creech RH; Catalano RB; Mastrangelo MJ; Engstrom PF
    Cancer; 1975 Apr; 35(4):1101-7. PubMed ID: 1116103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
    Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
    J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Breast neoplasms. Progress by means of adjuvant chemotherapy?].
    Senn HJ
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):10-5. PubMed ID: 6767909
    [No Abstract]   [Full Text] [Related]  

  • 77. Adjuvant chemotherapy in breast cancer.
    Bonadonna G; Rossi A; Tancini G; Valagussa P
    Lancet; 1983 May; 1(8334):1157. PubMed ID: 6133169
    [No Abstract]   [Full Text] [Related]  

  • 78. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
    Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
    Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
    [No Abstract]   [Full Text] [Related]  

  • 79. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.